First-in-human phase i study of PRS-050 (Angiocal), an anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumors

by Mross K., Richly H., Fischer R., Scharr D., Büchert M., Stern A., Gille H., Audoly L.P., Scheulen M.E.
Published 2019

mTORC1 inhibition restricts infammation-associated gastrointestinal tumorigenesis in mice

by Thiem, S., Pierce, T.P., Palmieri, M., Putoczki, T.L., Buchert, M., Preaudet, A., Farid, R.O., Love, C., Catimel, B., Lei, Z., Rozen, S., Gopalakrishnan, V., Schaper, F., Hallek, M., Boussioutas, A., Tan, P., Jarnicki, A., Ernst, M.
Published 2014